Please provide your email address to receive an email when new articles are posted on . Genitourinary syndrome of menopause is common but often underrecognized in dermatology. Low-dose vaginal ...

Please provide your email address to receive an email when new articles are posted on . Postmenopausal women with vulvovaginal atrophy treated with prasterone had lower UTI prevalence. Women who used ...

CHICAGO--(BUSINESS WIRE)--Dr. Lauren Streicher, a leading gynecologist and menopause expert, addresses the widespread issue of genitourinary syndrome of menopause (GSM) in her latest podcast episode.

It's important for clinicians to ask women whether they are experiencing symptoms of genitourinary syndrome of menopause (GSM) before and after menopause, according to a new statement from the North ...

Source: Getty Images Clinicians need to familiarize themselves with menopause genitourinary symptom management so they can address the pressing medical needs of millions of women. The GSM guideline ...

LJUBLJANA, Slovenia, Aug. 27, 2019 /CNW/ -- In an industry first achievement, Fotona's Dynamis Laser System received clearance by Health Canada, Canada's Food and Drugs Act and Regulations Agency, to ...

Genitourinary syndrome of menopause, urinary incontinence or vagina laxity can imply serious problems in terms of Women's quality of life and sexual health. Nowadays, beyond creams, moisturizers and ...

Vaginal atrophy is "incredibly common and underreported," says one OBGYN. From symptoms to treatments and prevention, here’s what experts want you to know.

As women age, they are more susceptible to vaginal dryness and pain during intercourse because of vulvovaginal atrophy (VVA). A new study suggests that ospemifene and systemic hormone therapy both ...